Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial

• Main Authors: Zhiyuan Xu (Author), Can Hu (Author), Jianfa Yu (Author), Yian Du (Author), Ping Hu (Author), Guofa Yu (Author), Conggang Hu (Author), Yu Zhang (Author), Wei Mao (Author), Shanqi Chen (Author), Xiangdong Cheng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Conversion therapy (surgical resection after chemotherapy) is a promising option for unresectable gastric cancer (GC) patients. Addition of anti-angiogenesis drug improves response to chemotherapy. Hence, this study explored the feasibility and efficacy of preoperative paclitaxel (PTX)/S1...